Clinical Trials Network, Ohio Valley Node U10DA013732
临床试验网络,俄亥俄谷节点 U10DA013732
基本信息
- 批准号:8606917
- 负责人:
- 金额:$ 112.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-09-30 至 2015-08-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemAccident and Emergency departmentAchievementAreaBilateralBuprenorphineCaringCharacteristicsClinicClinical SciencesClinical TrialsClinical Trials NetworkCollaborationsCommitCommunicationCommunitiesConduct Clinical TrialsContractsCountryDevelopmentDisciplineDoseEmergency MedicineEnsureEvaluationEvidence based practiceGoalsHealthHealth PersonnelHospitalsKentuckyKnowledgeLeadershipNational Institute of Drug AbuseOffice of Administrative ManagementOhioOpiate AddictionOpioidParticipantPatientsPharmaceutical PreparationsPrimary Health CareProtocols documentationResearchResearch PersonnelResearch TrainingSubstance abuse problemTechnology TransferTelemedicineTennesseeTestingTrainingTranslational ResearchVisionVisitWest VirginiaWorkaddictionbasedesigneffective therapyexperienceimprovedmembersubstance abuse treatmentsuccesstreatment program
项目摘要
DESCRIPTION (provided by applicant): From the beginning of its membership in NIDA's Clinical Trials Network (CTN) in 2000, the Ohio Valley Node (OVN) has been an effective, enthusiastic, and energetic node that has excelled in providing scientific and administrative leadership, in collaborating with other nodes and with NIDA and contract staff, and in disseminating information about evidence-based practices and the results of CTN studies. The OVN's Community Treatment Programs (CTPs) and its Regional Research and Training Center (RRTC) have worked together to create a node in which the CTN's goal of bilateral communication/collaboration between researchers and treatment providers has been fully realized. The success in integrating all members of this geographically dispersed node into a unified whole, together with the strong commitment of the Node PI, CTP PIs, and RRTC staff to full participation in the CTN, have enabled the OVN to be extremely productive throughout its membership in the CYN. The OVN has an experienced staff, including several RRTC and CTP PIs who have been with the OVN since its formation. The OVN continues to collaborate with a growing number of CTPs which have a variety of patient characteristics and extend over a broad geographical range now encompassing the entire Midwest (12 states) and the Upper-South states of Kentucky, Tennessee, and West Virginia. The 23 OVN CTPs, which together receive more than 100,000 patient visits a year, will contribute significantly to the number and variety of potential participants for CTN studies. The OVN administrative and management plans for the next five years capitalize on the strengths of the OVN: experience, teamwork, and varied areas of expertise (including HIV/AIDS, emergency medicine, integration of addiction treatment into primary care, and telemedicine), so the OVN can continue to contribute scientific leadership and excellence in developing/conducting CTN protocols. The OVN has detailed a research agenda designed to improve opioid dependence treatment by optimizing medication-assisted treatment and expanding office-based opioid treatment. Already cooperating actively with the four Addiction Technology and Transfer Centers (ATTCs) associated with the states covered by the OVN, the Node plans to strengthen relationships with other networks (e.g., Cincinnati Center for Clinical & Translational Science & Training).
描述(由申请人提供):自2000年加入NIDA的临床试验网络(CTN)以来,俄亥俄谷节点(OVN)一直是一个有效、热情和充满活力的节点,在提供科学和管理领导、与其他节点以及与NIDA和合同工作人员的合作以及传播关于循证实践和CTN研究结果方面表现出色。OVN的社区治疗方案(CTP)及其区域研究和培训中心(RRTC)共同努力,创建了一个节点,在该节点中,CTN的研究人员和治疗提供者之间的双边交流/合作的目标已经完全实现。成功地将这一地理上分散的节点的所有成员整合为一个统一的整体,再加上节点PI、CTP PI和RRTC工作人员对全面参与CTN的坚定承诺,使OVN在整个成员资格的整个过程中都非常富有成效。OVN拥有经验丰富的工作人员,包括几名RRTC和CTP PI,他们自OVN成立以来一直在OVN工作。OVN继续与越来越多的CTP合作,这些CTP具有各种患者特征,覆盖了广泛的地理范围,目前涵盖整个中西部(12个州)以及肯塔基州、田纳西州和西弗吉尼亚州的上南部各州。这23个OVN CTP每年总共接待超过10万名患者就诊,这将大大增加CTN研究的潜在参与者的数量和种类。OVN未来五年的行政和管理计划利用了OVN的优势:经验、团队合作和各种专业领域(包括艾滋病毒/艾滋病、急救医学、将成瘾治疗纳入初级保健和远程医疗),因此OVN可以继续在制定/执行CTN方案方面发挥科学领导作用和卓越表现。OVN详细介绍了一项研究议程,旨在通过优化药物辅助治疗和扩大办公室阿片类药物治疗来改善阿片依赖治疗。Node已经与OVN覆盖的州相关的四个成瘾技术和转移中心(ATTC)积极合作,计划加强与其他网络(例如,辛辛那提临床和翻译科学与培训中心)的关系。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
T John WINHUSEN其他文献
T John WINHUSEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('T John WINHUSEN', 18)}}的其他基金
The Ohio Valley Node of the Clinical Trials Network
临床试验网络俄亥俄谷节点
- 批准号:
10652032 - 财政年份:2022
- 资助金额:
$ 112.98万 - 项目类别:
The Ohio Valley Node of the Clinical Trials Network
临床试验网络俄亥俄谷节点
- 批准号:
10621497 - 财政年份:2022
- 资助金额:
$ 112.98万 - 项目类别:
The Ohio Valley Node of the Clinical Trials Network
临床试验网络俄亥俄谷节点
- 批准号:
10441828 - 财政年份:2021
- 资助金额:
$ 112.98万 - 项目类别:
The Ohio Valley Node of the Clinical Trials Network
临床试验网络俄亥俄谷节点
- 批准号:
10441986 - 财政年份:2021
- 资助金额:
$ 112.98万 - 项目类别:
EMPOWER: Evaluating the ability to reduce Morphine equivalent dose for chronic Pain patients receiving Opioid-therapy through a Web-based E-Health self-management program: a Randomized multi-site Clin
EMPOWER:评估通过基于网络的电子健康自我管理计划减少接受阿片类药物治疗的慢性疼痛患者吗啡当量剂量的能力:随机多站点临床
- 批准号:
10174898 - 财政年份:2017
- 资助金额:
$ 112.98万 - 项目类别:
A tailored, peer-delivered intervention to reduce recurring opioid overdoses
量身定制的、同行提供的干预措施,以减少反复出现的阿片类药物过量
- 批准号:
9352799 - 财政年份:2016
- 资助金额:
$ 112.98万 - 项目类别:
A tailored, peer-delivered intervention to reduce recurring opioid overdoses
量身定制的、同行提供的干预措施,以减少反复出现的阿片类药物过量
- 批准号:
9015947 - 财政年份:2016
- 资助金额:
$ 112.98万 - 项目类别:
Clinical Trials Network, Ohio Valley Node U10DA013732
临床试验网络,俄亥俄谷节点 U10DA013732
- 批准号:
8456472 - 财政年份:2000
- 资助金额:
$ 112.98万 - 项目类别:
Clinical Trials Network, Ohio Valley Node U10DA013732
临床试验网络,俄亥俄谷节点 U10DA013732
- 批准号:
8712426 - 财政年份:2000
- 资助金额:
$ 112.98万 - 项目类别:
Clinical Trials Network, Ohio Valley Node U10DA013732
临床试验网络,俄亥俄谷节点 U10DA013732
- 批准号:
8656498 - 财政年份:2000
- 资助金额:
$ 112.98万 - 项目类别:














{{item.name}}会员




